Product Code: Sample_DNA Extraction Kits Market - Global Outlook & Forecast 2022-2027_Arizton.pdf
The DNA Extraction Kit market by revenue is expected to grow at a CAGR of 7.7% during 2022-2027.
The center of the genomic revolution is DNA and the IT infrastructure to use it. The impacts are large in the healthcare segment. The recent advancements faster cancer detection, potentially saving thousands of lives globally. Genomic innovations based on DNA have evolved from gene editing to anti-cancer drugs. DNA is widely used as an initial sample for various diagnostics and research purposes. The extraction of DNA is a complex process. After the post introduction of DNA extraction kits, the process is simplified and can be carried out efficiently. The DNA extracted is primarily used to study the genetic cause of the disease, carry out forensic sciences, develop drugs, personalized medicines, paternity tests, and genome sequencing. Genomic advancements are playing a huge role in agricultural biology. They are a significant contributor to plant breeding technology, research like reducing the cost of crop production, and more.
One of the significant benefits is that the RNA/DNA extraction kits are available in various product types for multiple samples. The DNA extraction kit for microbial DNA extractions like Virus, Bacteria. DNA extraction kit for a tissue sample, DNA extraction kit for forensic DNA, Cell-Free DNA extraction kits, and more. This broader portfolio is increasing the end-users count for the DNA extraction kit market.
Technological Advancements are likely to drive the RNA/DNA Extraction Kit Market Growth
The demand for RNA/DNA extraction kits is increasing due to their usage of its applications. The DNA extracted is used in PCR, Genome sequencing, Cloning, and other applications. Increasing demand for this application will drive the demand for DNA Extraction kit market growth. Technological advancements like the introduction of next-generation DNA Extraction kits help the user to isolate the genomic DNA from a range of samples using optimized protocols. This helps the user to obtain high-quality DNA from even specialized samples. This is widely adopted by the researchers to work on multiple samples for the research purpose.
The usage of NGS is increasing in cancer research and personalized treatments. DNA extraction is seen as one of the basic and important steps in NGS library preparation. Increasing demand for personalized medicine, CAR-T therapies, Gene Therapies other regenerative medicines are largely accelerating the usage of DNA extraction kits in the market. In addition, the presence of several research institutes and standalone genomic labs in the developed countries like the US, The UK, Germany are largely involved in the genetic research, genome sequencing, studying genetic characteristics especially the diseased genes in cancer, neurological disorder segments, and other rare genetic diseases are largely driving the usage of the DNA isolation kits in the market.
COVID-19 had a negative impact on the market. The focus was on the RNA Extraction kits, this reduced the usage of DNA extraction kits and not many products were launched during the COVID-19 pandemic. Many genomic research centers were focused to sequence the COVID-19 variants and working for the vaccines. This largely diverted the genomic researchers to shift towards the COVID-19 samples, this largely reduced the DNA-based research or postponed and expected to regain post-COVID-19 pandemic ends.
Geographic Segmentation
North America dominated the DNA extraction kit market share. However, APAC is expected to grow at a faster rate with a CAGR of over 9% in the DNA extraction market. The increasing investments in genome sequencing, increasing adoption of genetic testing-based diagnostics for rare diseases, oncology, and higher adoption of personalized medicines are largely driving the North America Market.
- North America
- Europe
- APAC
- Latin America
- Middle East & Africa
THIS RESEARCH REPORT INCLUDE A DETAILED SEGMENTATION ANALYSIS BY:
- Product Type
- Application
- Sample Type
- End-User
- Geography
DNA Extraction Kit Market Segmentation Analysis
End-user: The health care facilities having in-house laboratories dominate the end-user segment. The number of samples tested for various genetic diseases, oncology is largely driving the healthcare segment to use the DNA extraction kit.
Sample Type: Blood, Tissue & FFPE samples dominated the sample type segment in the market. Blood, and tissue-based samples are largely used in the diagnostic segment in the market. FFPE samples which are preserved for the biopsy, experimental research, diagnostic, and drug development are large volume of samples that uses the DNA extraction process. These are major contributors to the DNA extraction kit market by sample type in the market.
Product Type: The cell-free DNA accounted for the major part of the product type. However, the genomic DNA segment is growing fast due to increased investments in genomic research and personalized medicines in the market. The Genomic DNA segment is expected to grow at a CAGR of 8.01% in the market.
Applications: PCR application is dominating the applications segment as PCR is a gold standard method to extract the DNA for various study purposes and diagnostics. The sequencing application is increasing significantly as there are technological advancements focused on genomic diagnostics.
Key Vendors
- Agilent Technologies
- Bio-Rad Laboratories
- F. Hoffmann-La Roche
- Promega
- QIAGEN
- Thermo Fisher Scientific
Other Prominent Vendors
- 1st BASE
- 3B BlackBio Biotech India
- BioChain Institute
- Bioneer
- BLIRT
- Canvax
- Cell Projects
- Covaris
- Cytiva
- Fivephoton Biochemicals
- Galenvs Sciences
- Geneaid Biotech
- IBI Scientific
- INVITEK Molecular
- LabTurbo
- Lexogen
- LGC Biosearch Technologies
- Lucigen
- MagGenome
- Merck
- MP BIOMEDICALS
- New England Biolabs
- Omega Bio-tek
- PCR Biosystems
- PerkinElmer
- Primerdesign
- Takara Bio
- Vivantis Technologies
- Xi'an Tianlong Science and Technology
- Zymo Research
KEY QUESTIONS ANSWERED
- 1. What will be the size of the global RNA/DNA extraction kit market by 2027?
- 2. Who are the key players in the DNA extraction kit industry?
- 3. Which region holds the highest share in the global RNA/DNA extraction kit market?
- 4. What are the latest trends in the market?
- 5. Which factors are influencing the DNA extraction kit market growth?
TABLE OF CONTENTS
1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
- 4.1 MARKET DEFINITION
- 4.1.1 INCLUSIONS
- 4.1.2 EXCLUSIONS
- 4.1.3 MARKET ESTIMATION CAVEATS
- 4.2 BASE YEAR
- 4.3 SCOPE OF THE STUDY
- 4.3.1 MARKET SEGMENTATION BY PRODUCT
- 4.3.2 MARKET SEGMENTATION BY APPLICATIONS
- 4.3.3 MARKET SEGMENTATION BY SAMPLE TYPE
- 4.3.4 MARKET SEGMENTATION BY END-USER
- 4.3.5 MARKET SEGMENTATION BY GEOGRAPHY
5 REPORT ASSUMPTIONS & CAVEATS
- 5.1 KEY CAVEATS
- 5.2 CURRENCY CONVERSION
- 5.3 MARKET DERIVATION
6 MARKET AT A GLANCE
7 INTRODUCTION
- 7.1 OVERVIEW
- 7.2 MARKET SYNOPSIS
- 7.2.1 DNA EXTRACTION KITS MARKET OVERVIEW
- 7.2.2 TECHNOLOGICAL ADVANCES ARE LIKELY TO DRIVE THE DNA EXTRACTION KITS MARKET GROWTH
- 7.2.3 GEOGRAPHIC SEGMENTATION
8 MARKET OPPORTUNITIES & TRENDS
- 8.1 AVAILABILITY OF NEXT-GENERATION DNA EXTRACTION KITS
- 8.2 RISE IN R&D ACTIVITIES IN GENOMICS
- 8.3 TECHNOLOGICAL ADVANCES IN DNA EXTRACTION KITS
- 8.4 INCREASE IN GENOMICS & REGENERATIVE MEDICINE PROJECTS
9 MARKET GROWTH ENABLERS
- 9.1 RISE IN PRODUCT LAUNCHES
- 9.2 MORE PATIENTS WITH GENETIC DISORDERS
- 9.3 INCREASED USE OF DNA EXTRACTION KITS IN GENOMICS
10 MARKET RESTRAINTS
- 10.1 INFLUENCE OF THE COVID-19 PANDEMIC
- 10.2 LOW PENETRATION OF MOLECULAR & GENOMIC DIAGNOSTICS IN LMICS
- 10.3 HIGH COST OF DNA EXTRACTION KITS & IMPURE RESULTS
11 MARKET LANDSCAPE
- 11.1 MARKET OVERVIEW
- 11.2 MARKET SIZE & FORECAST
- 11.2.1 GEOGRAPHY INSIGHTS
- 11.2.2 PRODUCT INSIGHTS
- 11.2.3 APPLICATIONS INSIGHT
- 11.2.4 SAMPLE TYPE INSIGHTS
- 11.2.5 END-USER INSIGHTS
- 11.3 FIVE FORCES ANALYSIS
- 11.3.1 THREAT OF NEW ENTRANTS
- 11.3.2 BARGAINING POWER OF SUPPLIERS
- 11.3.3 BARGAINING POWER OF BUYERS
- 11.3.4 THREAT OF SUBSTITUTES
- 11.3.5 COMPETITIVE RIVALRY
12 PRODUCT
- 12.1 MARKET SNAPSHOT & GROWTH ENGINE
- 12.2 MARKET OVERVIEW
- 12.3 CELL-FREE DNA
- 12.3.1 MARKET OVERVIEW
- 12.3.2 MARKET SIZE & FORECAST
- 12.3.3 CELL-FREE DNA SEGMENTATION BY GEOGRAPHY
- 12.4 GENOMIC DNA
- 12.4.1 MARKET OVERVIEW
- 12.4.2 MARKET SIZE & FORECAST
- 12.4.3 GENOMIC DNA SEGMENTATION BY GEOGRAPHY
- 12.5 OTHERS
- 12.5.1 MARKET OVERVIEW
- 12.5.2 MARKET SIZE & FORECAST
- 12.5.3 OTHERS SEGMENTATION BY GEOGRAPHY
13 APPLICATIONS
- 13.1 MARKET SNAPSHOT & GROWTH ENGINE
- 13.2 MARKET OVERVIEW
- 13.3 PCR
- 13.3.1 MARKET OVERVIEW
- 13.3.2 MARKET SIZE & FORECAST
- 13.3.3 PCR SEGMENTATION BY GEOGRAPHY
- 13.4 SEQUENCING
- 13.4.1 MARKET OVERVIEW
- 13.4.2 MARKET SIZE & FORECAST
- 13.4.3 SEQUENCING SEGMENTATION BY GEOGRAPHY
- 13.5 CLONING
- 13.5.1 MARKET OVERVIEW
- 13.5.2 MARKET SIZE & FORECAST
- 13.5.3 CLONING SEGMENTATION BY GEOGRAPHY
- 13.6 OTHERS
- 13.6.1 MARKET OVERVIEW
- 13.6.2 MARKET SIZE & FORECAST
- 13.6.3 OTHER APPLICATION SEGMENTATION BY GEOGRAPHY
14 SAMPLE TYPE
- 14.1 MARKET SNAPSHOT & GROWTH ENGINE
- 14.2 MARKET OVERVIEW
- 14.3 BLOOD, TISSUE & FFPE
- 14.3.1 MARKET OVERVIEW
- 14.3.2 MARKET SIZE & FORECAST
- 14.3.3 BLOOD, TISSUE & FFPE SEGMENTATION BY GEOGRAPHY
- 14.4 CELLS
- 14.4.1 MARKET OVERVIEW
- 14.4.2 MARKET SIZE & FORECAST
- 14.4.3 CELLS SEGMENTATION BY GEOGRAPHY
- 14.5 OTHERS
- 14.5.1 MARKET OVERVIEW
- 14.5.2 MARKET SIZE & FORECAST
- 14.5.3 OTHER SAMPLE TYPE SEGMENTATION BY GEOGRAPHY
15 END-USER
- 15.1 MARKET SNAPSHOT & GROWTH ENGINE
- 15.2 MARKET OVERVIEW
- 15.3 HEALTHCARE FACILITIES
- 15.3.1 MARKET OVERVIEW
- 15.3.2 MARKET SIZE & FORECAST
- 15.3.3 HEALTHCARE FACILITIES SEGMENTATION BY GEOGRAPHY
- 15.4 RESEARCH INSTITUTES
- 15.4.1 MARKET OVERVIEW
- 15.4.2 MARKET SIZE & FORECAST
- 15.4.3 RESEARCH INSTITUTES BY GEOGRAPHY
- 15.5 PHARMA & BIOTECH COMPANIES
- 15.5.1 MARKET OVERVIEW
- 15.5.2 MARKET SIZE & FORECAST
- 15.5.3 PHARMA & BIOTECH COMPANIES BY GEOGRAPHY
- 15.6 OTHERS
- 15.6.1 MARKET OVERVIEW
- 15.6.2 MARKET SIZE & FORECAST
- 15.6.3 OTHER END-USER SEGMENTATION BY GEOGRAPHY
16 GEOGRAPHY
- 16.1 MARKET SNAPSHOT & GROWTH ENGINE
- 16.2 GEOGRAPHIC OVERVIEW
17 NORTH AMERICA
- 17.1 MARKET OVERVIEW
- 17.2 MARKET SIZE & FORECAST
- 17.2.1 NORTH AMERICA BY PRODUCT SEGMENTATION
- 17.2.2 NORTH AMERICA BY APPLICATIONS SEGMENTATION
- 17.2.3 NORTH AMERICA BY SAMPLE TYPE SEGMENTATION
- 17.2.4 NORTH AMERICA BY END-USER SEGMENTATION
- 17.3 KEY COUNTRIES
- 17.3.1 US: MARKET SIZE & FORECAST
- 17.3.2 CANADA: MARKET SIZE & FORECAST
18 EUROPE
- 18.1 MARKET OVERVIEW
- 18.2 MARKET SIZE & FORECAST
- 18.2.1 EUROPE BY PRODUCT SEGMENTATION
- 18.2.2 EUROPE BY APPLICATIONS SEGMENTATION
- 18.2.3 EUROPE BY SAMPLE TYPE SEGMENTATION
- 18.2.4 EUROPE BY END-USER SEGMENTATION
- 18.3 KEY COUNTRIES
- 18.3.1 GERMANY: MARKET SIZE & FORECAST
- 18.3.2 FRANCE: MARKET SIZE & FORECAST
- 18.3.3 UK: MARKET SIZE & FORECAST
- 18.3.4 ITALY: MARKET SIZE & FORECAST
- 18.3.5 SPAIN: MARKET SIZE & FORECAST
19 APAC
- 19.1 MARKET OVERVIEW
- 19.2 MARKET SIZE & FORECAST
- 19.2.1 APAC BY PRODUCT SEGMENTATION
- 19.2.2 APAC BY APPLICATIONS SEGMENTATION
- 19.2.3 APAC BY SAMPLE TYPE SEGMENTATION
- 19.2.4 APAC BY END-USER SEGMENTATION
- 19.3 KEY COUNTRIES
- 19.3.1 CHINA: MARKET SIZE & FORECAST
- 19.3.2 JAPAN: MARKET SIZE & FORECAST
- 19.3.3 INDIA: MARKET SIZE & FORECAST
- 19.3.4 SOUTH KOREA: MARKET SIZE & FORECAST
- 19.3.5 AUSTRALIA: MARKET SIZE & FORECAST
20 LATIN AMERICA
- 20.1 MARKET OVERVIEW
- 20.2 MARKET SIZE & FORECAST
- 20.2.1 LATIN AMERICA BY PRODUCT SEGMENTATION
- 20.2.2 LATIN AMERICA BY APPLICATIONS SEGMENTATION
- 20.2.3 LATIN AMERICA BY SAMPLE TYPE SEGMENTATION
- 20.2.4 LATIN AMERICA BY END-USER SEGMENTATION
- 20.3 KEY COUNTRIES
- 20.3.1 BRAZIL: MARKET SIZE & FORECAST
- 20.3.2 MEXICO: MARKET SIZE & FORECAST
- 20.3.3 ARGENTINA: MARKET SIZE & FORECAST
21 MIDDLE EAST & AFRICA
- 21.1 MARKET OVERVIEW
- 21.2 MARKET SIZE & FORECAST
- 21.2.1 MIDDLE EAST & AFRICA BY PRODUCT SEGMENTATION
- 21.2.2 MIDDLE EAST & AFRICA BY APPLICATIONS SEGMENTATION
- 21.2.3 MIDDLE EAST & AFRICA BY SAMPLE TYPE SEGMENTATION
- 21.2.4 MIDDLE EAST & AFRICA BY END-USER SEGMENTATION
- 21.3 KEY COUNTRIES
- 21.3.1 TURKEY: MARKET SIZE & FORECAST
- 21.3.2 SAUDI ARABIA: MARKET SIZE & FORECAST
- 21.3.3 SOUTH AFRICA: MARKET SIZE & FORECAST
22 COMPETITIVE LANDSCAPE
- 22.1 COMPETITION OVERVIEW
- 22.2 MARKET SHARE ANALYSIS
- 22.2.1 AGILENT TECHNOLOGIES
- 22.2.2 BIO-RAD LABORATORIES
- 22.2.3 F. HOFFMANN-LA ROCHE
- 22.2.4 PROMEGA
- 22.2.5 QIAGEN
- 22.2.6 THERMO FISHER SCIENTIFIC
23 KEY COMPANY PROFILES
- 23.1 AGILENT TECHNOLOGIES
- 23.1.1 BUSINESS OVERVIEW
- 23.1.2 PRODUCT OFFERINGS
- 23.1.3 KEY STRATEGIES
- 23.1.4 KEY STRENGTHS
- 23.1.5 KEY OPPORTUNITIES
- 23.2 BIO-RAD LABORATORIES
- 23.2.1 BUSINESS OVERVIEW
- 23.2.2 PRODUCT OFFERINGS
- 23.2.3 KEY STRATEGIES
- 23.2.4 KEY STRENGTHS
- 23.2.5 KEY OPPORTUNITIES
- 23.3 F. HOFFMANN-LA ROCHE
- 23.3.1 BUSINESS OVERVIEW
- 23.3.2 PRODUCT OFFERINGS
- 23.3.3 KEY STRATEGIES
- 23.3.4 KEY STRENGTHS
- 23.3.5 KEY OPPORTUNITIES
- 23.4 PROMEGA
- 23.4.1 BUSINESS OVERVIEW
- 23.4.2 PRODUCT OFFERINGS
- 23.4.3 KEY STRATEGIES
- 23.4.4 KEY STRENGTHS
- 23.4.5 KEY OPPORTUNITIES
- 23.5 QIAGEN
- 23.5.1 BUSINESS OVERVIEW
- 23.5.2 PRODUCT OFFERINGS
- 23.5.3 KEY STRATEGIES
- 23.5.4 KEY STRENGTHS
- 23.5.5 KEY OPPORTUNITIES
- 23.6 THERMO FISHER SCIENTIFIC
- 23.6.1 BUSINESS OVERVIEW
- 23.6.2 PRODUCT OFFERINGS
- 23.6.3 KEY STRATEGIES
- 23.6.4 KEY STRENGTHS
- 23.6.5 KEY OPPORTUNITIES
24 OTHER PROMINENT VENDORS
- 24.1 1ST BASE
- 24.1.1 BUSINESS OVERVIEW
- 24.1.2 PRODUCT OFFERINGS
- 24.2 3B BLACKBIO BIOTECH INDIA
- 24.2.1 BUSINESS OVERVIEW
- 24.2.2 PRODUCT OFFERINGS
- 24.3 BIOCHAIN INSTITUTE
- 24.3.1 BUSINESS OVERVIEW
- 24.3.2 PRODUCT OFFERINGS
- 24.4 BIONEER
- 24.4.1 BUSINESS OVERVIEW
- 24.4.2 PRODUCT OFFERINGS
- 24.5 BLIRT
- 24.5.1 BUSINESS OVERVIEW
- 24.5.2 PRODUCT OFFERINGS
- 24.6 CANVAX
- 24.6.1 BUSINESS OVERVIEW
- 24.6.2 PRODUCT OFFERINGS
- 24.7 CELL PROJECTS
- 24.7.1 BUSINESS OVERVIEW
- 24.7.2 PRODUCT OFFERINGS
- 24.8 COVARIS
- 24.8.1 BUSINESS OVERVIEW
- 24.8.2 PRODUCT OFFERINGS
- 24.9 CYTIVA
- 24.9.1 BUSINESS OVERVIEW
- 24.9.1 PRODUCT OFFERINGS
- 24.10 FIVEPHOTON BIOCHEMICALS
- 24.10.1 BUSINESS OVERVIEW
- 24.10.2 PRODUCT OFFERINGS
- 24.11 GALENVS SCIENCES
- 24.11.1 BUSINESS OVERVIEW
- 24.11.2 PRODUCT OFFERINGS
- 24.12 GENEAID BIOTECH
- 24.12.1 BUSINESS OVERVIEW
- 24.12.2 PRODUCT OFFERINGS
- 24.13 IBI SCIENTIFIC
- 24.13.1 BUSINESS OVERVIEW
- 24.13.2 PRODUCT OFFERINGS
- 24.14 INVITEK MOLECULAR
- 24.14.1 BUSINESS OVERVIEW
- 24.14.2 PRODUCT OFFERINGS
- 24.15 LABTURBO
- 24.15.1 BUSINESS OVERVIEW
- 24.15.2 PRODUCT OFFERINGS
- 24.16 LEXOGEN
- 24.16.1 BUSINESS OVERVIEW
- 24.16.2 PRODUCT OFFERINGS
- 24.17 LGC BIOSEARCH TECHNOLOGIES
- 24.17.1 BUSINESS OVERVIEW
- 24.17.2 PRODUCT OFFERINGS
- 24.18 LUCIGEN
- 24.18.1 BUSINESS OVERVIEW
- 24.18.2 PRODUCT OFFERINGS
- 24.19 MAGGENOME
- 24.19.1 BUSINESS OVERVIEW
- 24.19.2 PRODUCT OFFERINGS
- 24.20 MERCK KGAA
- 24.20.1 BUSINESS OVERVIEW
- 24.20.2 PRODUCT OFFERINGS
- 24.21 MP BIOMEDICALS
- 24.21.1 BUSINESS OVERVIEW
- 24.21.2 PRODUCT OFFERINGS
- 24.22 NEW ENGLAND BIOLABS
- 24.22.1 BUSINESS OVERVIEW
- 24.22.2 PRODUCT OFFERINGS
- 24.23 OMEGA BIO-TEK
- 24.23.1 BUSINESS OVERVIEW
- 24.23.2 PRODUCT OFFERINGS
- 24.24 PCR BIOSYSTEMS
- 24.24.1 BUSINESS OVERVIEW
- 24.24.2 PRODUCT OFFERINGS
- 24.25 PERKINELMER
- 24.25.1 BUSINESS OVERVIEW
- 24.25.2 PRODUCT OFFERINGS
- 24.26 PRIMERDESIGN
- 24.26.1 BUSINESS OVERVIEW
- 24.26.2 PRODUCT OFFERINGS
- 24.27 TAKARA BIO
- 24.27.1 BUSINESS OVERVIEW
- 24.27.2 PRODUCT OFFERINGS
- 24.28 VIVANTIS TECHNOLOGIES
- 24.28.1 BUSINESS OVERVIEW
- 24.28.2 PRODUCT OFFERINGS
- 24.29 XI'AN TIANLONG SCIENCE AND TECHNOLOGY
- 24.29.1 BUSINESS OVERVIEW
- 24.29.2 PRODUCT OFFERINGS
- 24.30 ZYMO RESEARCH
- 24.30.1 BUSINESS OVERVIEW
- 24.30.2 PRODUCT OFFERINGS
25 REPORT SUMMARY
- 25.1 KEY TAKEAWAYS
- 25.2 STRATEGIC RECOMMENDATIONS
26 QUANTITATIVE SUMMARY
- 26.1.1 PRODUCT
- 26.1.2 NORTH AMERICA: PRODUCT SEGMENTATION
- 26.1.3 EUROPE: PRODUCT SEGMENTATION
- 26.1.4 APAC: PRODUCT SEGMENTATION
- 26.1.5 LATIN AMERICA: PRODUCT SEGMENTATION
- 26.1.6 MIDDLE EAST & AFRICA: PRODUCT SEGMENTATION
- 26.2 APPLICATIONS
- 26.2.1 NORTH AMERICA: APPLICATIONS SEGMENTATION
- 26.2.2 EUROPE: APPLICATIONS SEGMENTATION
- 26.2.3 APAC: APPLICATIONS SEGMENTATION
- 26.2.4 LATIN AMERICA: APPLICATIONS SEGMENTATION
- 26.2.5 MIDDLE EAST & AFRICA: APPLICATIONS SEGMENTATION
- 26.3 MARKET BY SAMPLE TYPE
- 26.3.1 NORTH AMERICA: SAMPLE TYPE SEGMENTATION
- 26.3.2 EUROPE: SAMPLE TYPE SEGMENTATION
- 26.3.3 APAC: SAMPLE TYPE SEGMENTATION
- 26.3.4 LATIN AMERICA: SAMPLE TYPE SEGMENTATION
- 26.3.5 MIDDLE EAST & AFRICA: SAMPLE TYPE SEGMENTATION
- 26.4 END-USER
- 26.4.1 NORTH AMERICA: END-USER SEGMENTATION
- 26.4.2 EUROPE: END-USER SEGMENTATION
- 26.4.3 APAC: END-USER SEGMENTATION
- 26.4.4 LATIN AMERICA: END-USER SEGMENTATION
- 26.4.5 MIDDLE EAST & AFRICA: END-USER SEGMENTATION
- 26.5 GEOGRAPHY
- 26.5.1 CELL-FREE DNA SEGMENTATION BY GEOGRAPHY
- 26.5.2 GENOMIC DNA SEGMENTATION BY GEOGRAPHY
- 26.5.3 OTHERS PRODUCT SEGMENTATION BY GEOGRAPHY
- 26.5.4 PCR SEGMENTATION BY GEOGRAPHY
- 26.5.5 SEQUENCING SEGMENTATION BY GEOGRAPHY
- 26.5.6 CLONING SEGMENTATION BY GEOGRAPHY
- 26.5.7 OTHER APPLICATION SEGMENTATION BY GEOGRAPHY
- 26.5.8 BLOOD, TISSUE & FFPE SEGMENTATION BY GEOGRAPHY
- 26.5.9 CELLS SEGMENTATION BY GEOGRAPHY
- 26.5.10 OTHER SAMPLE TYPE SEGMENTATION BY GEOGRAPHY
- 26.5.11 HEALTHCARE FACILITIES SEGMENTATION BY GEOGRAPHY
- 26.5.12 RESEARCH INSTITUTES SEGMENTATION BY GEOGRAPHY
- 26.5.13 PHARMA & BIOTECH COMPANIES SEGMENTATION BY GEOGRAPHY
- 26.5.14 OTHER END-USERS SEGMENTATION BY GEOGRAPHY
27 APPENDIX